#Post ADS3

advertisement

Nitroglycerin0.5/2.6

Ingredients: nitroglycerin USD 0.5 mg Sabli Nguel Tablet and Nitroglycerin USD 2.6 mg Sustainable Release Tablet
Nitroglycerin_Drugs club

Instructions: Nitroglycerin USD 0.5 mg Tablet refers to the preventive treatment of angina-related pain or anti-coronary artery disease-related enzina pectoris.
Nitroglycerin SR tablet: It is directed at the preventive treatment of Chronic Stable Enigina Pectoris.

Dimensions and Usage: Nitroglycerin USA 0.5 mg. Tablet: With the first symptom of the angina attack, 1 tablet will be given below the tongue. It can be repeated at the same level every 5 minutes until pain is relieved. If you still have pain after taking 3 tablets for 15 minutes, then you may be advised for immediate hospital admission. Nitroglycerin SR tablet: According to the requirements of each patient, the levels of medicines are worth noting, but usually 1 to 2 tablets can be given 3 times per day.

Counter & Warnings: Reproductive to Myocardial Informations, Acute Bloodlessness, Increased Intracranial Pressure and Those Who Have Sensitivity To Nitroglycerin Those patients who should not use nitroglycerin in patients who have anemia, hypertension, cerebral hemorrhage, closed angle glucoma, nitrates, sensitivity to low blood pressure, hypo-vellemia, hypertropic obstructive cardiomyopathy, aortic stenosis, cardiac temporates, constructive pericarditis and metastatic disfusion. It is referred to those patients who are taking sildenafel cetrera.

Side effect: Face on face, headache, headache and positional lower blood pressure which is caused by Reefex tachycardia or paradoxical bradycardiae.

Reactions with other drugs: Low blood pressure may occur due to anti-hypertensive, beta-blockers or phenothaginas and patients taking nitrates. If used with calcium channel blocker nitrates, it can cause low thoracic acid. Low blood pressure may occur even when taking nitrates and alcohol together. Vitodialitarian and hemodial effects of nitroglycerin may increase with the taking of aspirin. Patients who are taking sub-penile nitroglycerin should refrain from avoiding aromatomin and aromatomin medicines or observe the symptoms of arthritis.

Use during pregnancy and breastfeeding: There is no evidence of nitroglycerin's safety during pregnancy and breastfeeding. Neutoglycerin should not be given to pregnant and breastfeeding mothers without consulting the doctor. It is not known whether breast-feeding nitroglycerin is released.

Use in children: Not directed towards children.

āĻ‰āĻĒাāĻĻাāĻ¨ : āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻ‡āĻ‰āĻāĻ¸āĻĒি ā§Ļ.ā§Ģ āĻŽি.āĻ—্āĻ°া. āĻ¸াāĻŦāĻ˛ি āĻ™্āĻ—ুāĻ¯়েāĻ˛ āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ āĻāĻŦং āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻ‡āĻ‰āĻāĻ¸āĻĒি ā§¨.ā§Ŧ āĻŽি.āĻ—্āĻ°া. āĻ¸াāĻ¸āĻŸেāĻ‡āĻ¨āĻĄ āĻ°িāĻ˛িāĻœ āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ।

āĻ¨িāĻ°্āĻĻেāĻļāĻ¨া : āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻ‡āĻ‰āĻāĻ¸āĻĒি ā§Ļ.ā§Ģ āĻŽি.āĻ—্āĻ°া. āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ āĻāĻŸি āĻāĻ¨āĻœিāĻ¨া āĻœāĻ¨িāĻ¤ āĻŦ্āĻ¯āĻĨা āĻ‰āĻĒāĻļāĻŽ āĻ…āĻĨāĻŦা āĻ•āĻ°োāĻ¨াāĻ°ী āĻ†āĻ°্āĻŸাāĻ°ী āĻĄিāĻœিāĻœ āĻœāĻ¨িāĻ¤ āĻāĻ¨āĻœিāĻ¨া āĻĒেāĻ•āĻŸোāĻ°িāĻ¸ āĻāĻ° āĻĒ্āĻ°āĻ¤িāĻˇেāĻ§āĻ•āĻŽূāĻ˛āĻ• āĻšিāĻ•িā§ŽāĻ¸াāĻ¯় āĻ¨িāĻ°্āĻĻেāĻļিāĻ¤।
āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻāĻ¸ āĻ†āĻ° āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ: āĻāĻŸি āĻ•্āĻ°āĻŖিāĻ• āĻ¸্āĻŸ্āĻ¯াāĻŦāĻ˛ āĻāĻ¨āĻœিāĻ¨া āĻĒেāĻ•āĻŸোāĻ°িāĻ¸ āĻāĻ° āĻĒ্āĻ°āĻ¤িāĻˇেāĻ§āĻ•āĻŽূāĻ˛āĻ• āĻšিāĻ•িā§ŽāĻ¸াāĻ¯় āĻ¨িāĻ°্āĻĻেāĻļিāĻ¤।

āĻŽাāĻ¤্āĻ°া āĻ“ āĻŦ্āĻ¯āĻŦāĻšাāĻ°āĻŦিāĻ§ি : āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻ‡āĻ‰āĻāĻ¸āĻĒি ā§Ļ.ā§Ģ āĻŽি.āĻ—্āĻ°া. āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ: āĻāĻ¨āĻœিāĻ¨া āĻ…্āĻ¯াāĻŸাāĻ•েāĻ° āĻĒ্āĻ°āĻĨāĻŽ āĻ˛āĻ•্āĻˇāĻŖেāĻ° āĻ¸াāĻĨে āĻ¸াāĻĨে ā§§āĻŸি āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ āĻœিāĻš্āĻŦাāĻ° āĻ¨ীāĻšে āĻĻিāĻ¤ে āĻšāĻŦে। āĻŦ্āĻ¯āĻĨা āĻ‰āĻĒāĻļāĻŽ āĻ¨া āĻšāĻ“āĻ¯়া āĻĒāĻ°্āĻ¯āĻ¨্āĻ¤ āĻĒ্āĻ°āĻ¤ি ā§Ģ āĻŽিāĻ¨িāĻŸ āĻ…āĻ¨্āĻ¤āĻ° āĻāĻ•āĻ‡ āĻŽাāĻ¤্āĻ°াāĻ¯় āĻĒুāĻ¨āĻ°াāĻŦৃāĻ¤্āĻ¤ি āĻ•āĻ°া āĻ¯েāĻ¤ে āĻĒাāĻ°ে। āĻ¯āĻĻি ā§§ā§Ģ āĻŽিāĻ¨িāĻŸ āĻ§āĻ°ে ā§ŠāĻŸি āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ āĻ—্āĻ°āĻšāĻŖ āĻ•āĻ°াāĻ° āĻĒāĻ°েāĻ“ āĻŦ্āĻ¯āĻĨা āĻŦāĻœাāĻ¯় āĻĨাāĻ•ে āĻ¤াāĻšāĻ˛ে āĻ¤াā§ŽāĻ•্āĻˇāĻŖিāĻ• āĻšাāĻ¸āĻĒাāĻ¤াāĻ˛ে āĻ­āĻ°্āĻ¤িāĻ° āĻœāĻ¨্āĻ¯ āĻĒāĻ°াāĻŽāĻ°্āĻļ āĻĻেāĻ¯়া āĻ¯েāĻ¤ে āĻĒাāĻ°ে। āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻāĻ¸ āĻ†āĻ° āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ: āĻĒ্āĻ°āĻ¤্āĻ¯েāĻ• āĻ°োāĻ—ীāĻ° āĻĒ্āĻ°āĻ¯়োāĻœāĻ¨ীāĻ¯়āĻ¤া āĻ…āĻ¨ুāĻ¸াāĻ°ে āĻ“āĻˇুāĻ§েāĻ° āĻŽাāĻ¤্āĻ°া āĻ¨িāĻ°্āĻ§াāĻ°āĻŖ āĻ¯োāĻ—্āĻ¯ āĻ•িāĻ¨্āĻ¤ু āĻ¸াāĻ§াāĻ°āĻŖāĻ¤ ā§§-ā§¨āĻŸি āĻŸ্āĻ¯াāĻŦāĻ˛েāĻŸ āĻĻিāĻ¨ে ā§Š āĻŦাāĻ° āĻĻেāĻ¯়া āĻ¯েāĻ¤ে āĻĒাāĻ°ে।

āĻĒ্āĻ°āĻ¤িāĻ¨িāĻ°্āĻĻেāĻļāĻ¨া āĻ“ āĻ¸āĻ¤āĻ°্āĻ•āĻ¤া : āĻŽাāĻ¯়োāĻ•াāĻ°্āĻĄিāĻ¯়াāĻ˛ āĻ‡āĻ¨āĻĢাāĻ°āĻ•āĻļāĻ¨, āĻ¤ীāĻŦ্āĻ° āĻ°āĻ•্āĻ¤āĻ¸্āĻŦāĻ˛্āĻĒāĻ¤া, āĻŦāĻ°্āĻ§িāĻ¤ āĻ‡āĻ¨্āĻŸ্āĻ°াāĻ•্āĻ°েāĻ¨িāĻ¯়াāĻ˛ āĻšাāĻĒ āĻāĻŦং āĻ¯াāĻĻেāĻ° āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻāĻ° āĻĒ্āĻ°āĻ¤ি āĻ…āĻ¤ি āĻ¸ংāĻŦেāĻĻāĻ¨āĻļীāĻ˛āĻ¤া āĻ†āĻ›ে āĻ¤াāĻĻেāĻ° āĻœāĻ¨্āĻ¯ āĻĒ্āĻ°āĻ¤িāĻ¨িāĻ°্āĻĻেāĻļিāĻ¤। āĻ¯েāĻ¸āĻŦ āĻ°োāĻ—ীāĻĻেāĻ° āĻ°āĻ•্āĻ¤āĻ¸āĻ˛্āĻĒāĻ¤া, āĻ¸্āĻ¨াāĻ¯়ুāĻ°োāĻ—, āĻ¸েāĻ°েāĻŦ্āĻ°াāĻ˛ āĻšেāĻŽোāĻ°েāĻœ, āĻ•্āĻ˛োāĻœāĻĄ āĻāĻ™্āĻ—েāĻ˛ āĻ—্āĻ˛ুāĻ•োāĻŽা, āĻ¨াāĻ‡āĻŸ্āĻ°েāĻŸāĻ¸ āĻāĻ° āĻĒ্āĻ°āĻ¤ি āĻ¸ংāĻŦেāĻĻāĻ¨āĻļীāĻ˛āĻ¤া, āĻ¨িāĻŽ্āĻ¨ āĻ°āĻ•্āĻ¤āĻšাāĻĒ, āĻšাāĻ‡āĻĒো-āĻ­āĻ˛েāĻŽিāĻ¯়া, āĻšাāĻ‡āĻĒাāĻ°āĻŸ্āĻ°āĻĒিāĻ• āĻ…āĻŦāĻ¸āĻŸ্āĻ°াāĻ•āĻŸিāĻ­ āĻ•াāĻ°্āĻĄিāĻ“āĻŽাāĻ¯়োāĻĒেāĻĨি, āĻ…্āĻ¯াāĻ“āĻ°্āĻŸিāĻ• āĻ¸্āĻŸেāĻ¨োāĻ¸িāĻ¸, āĻ•াāĻ°্āĻĄিāĻ¯়াāĻ• āĻŸেāĻŽ্āĻĒোāĻ¨েāĻĄ, āĻ•āĻ¨āĻ¸্āĻŸ্āĻ°িāĻ•āĻŸিāĻ­ āĻĒেāĻ°িāĻ•াāĻ°্āĻĄাāĻ‡āĻŸিāĻ¸ āĻāĻŦং āĻ…āĻ°্āĻĨোāĻ¸্āĻŸ্āĻ¯াāĻŸিāĻ• āĻĄিāĻ¸āĻĢাংāĻļāĻ¨ āĻ†āĻ›ে āĻ¤াāĻĻেāĻ° āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻŦ্āĻ¯āĻŦāĻšাāĻ° āĻ•āĻ°া āĻ‰āĻšিāĻ¤ āĻ¨āĻ¯়। āĻ¯েāĻ¸āĻŦ āĻ°োāĻ—ী āĻ¸িāĻ˛āĻĄেāĻ¨াāĻĢিāĻ˛ āĻ¸াāĻ‡āĻŸ্āĻ°েāĻŸ āĻ—্āĻ°āĻšāĻŖ āĻ•āĻ°āĻ›ে āĻ¤াāĻĻেāĻ° āĻ•্āĻˇেāĻ¤্āĻ°ে āĻāĻŸি āĻĒ্āĻ°āĻ¤িāĻ¨িāĻ°্āĻĻেāĻļিāĻ¤।

āĻĒাāĻ°্āĻļ্āĻŦ āĻĒ্āĻ°āĻ¤িāĻ•্āĻ°িāĻ¯়া : āĻŽুāĻ–āĻŽāĻ¨্āĻĄāĻ˛ে āĻ°āĻ•্āĻ¤িāĻŽাāĻ­াāĻŦ, āĻŽাāĻĨাāĻŦ্āĻ¯āĻĨা, āĻŽাāĻĨাāĻ˜োāĻ°াāĻ¨ো āĻāĻŦং āĻ…āĻŦāĻ¸্āĻĨাāĻ¨āĻ—āĻ¤ āĻ¨িāĻŽ্āĻ¨ āĻ°āĻ•্āĻ¤āĻšাāĻĒ āĻ¯া āĻ°িāĻĢেāĻ•্āĻ¸ āĻŸ্āĻ¯াāĻ•িāĻ•াāĻ°্āĻĄিāĻ¯়া āĻ…āĻĨāĻŦা āĻĒ্āĻ¯াāĻ°াāĻĄāĻ•্āĻ¸িāĻ•াāĻ˛ āĻŦ্āĻ°্āĻ¯াāĻĄিāĻ•াāĻ°্āĻĄিāĻ¯়াāĻ° āĻ•াāĻ°āĻŖে āĻ¸ংāĻ˜āĻŸিāĻ¤ āĻšāĻ¯়।

āĻ…āĻ¨্āĻ¯ āĻ“āĻˇুāĻ§েāĻ° āĻ¸াāĻĨে āĻĒ্āĻ°āĻ¤িāĻ•্āĻ°িāĻ¯়া : āĻāĻ¨্āĻŸি-āĻšাāĻ‡āĻĒাāĻ°āĻŸেāĻ¨āĻ¸িāĻ­, āĻŦিāĻŸা-āĻŦ্āĻ˛āĻ•াāĻ° āĻ…āĻĨāĻŦা āĻĢেāĻ¨োāĻĨাāĻ¯়াāĻœিāĻ¨āĻ¸ āĻāĻŦং āĻ¨াāĻ‡āĻŸ্āĻ°েāĻŸāĻ¸ āĻ—্āĻ°āĻšāĻŖāĻ•াāĻ°ী āĻ°োāĻ—ীāĻĻেāĻ° āĻ•্āĻˇেāĻ¤্āĻ°ে āĻ¸ংāĻ¯োāĻœিāĻ¤ āĻ¨িāĻŽ্āĻ¨ āĻ°āĻ•্āĻ¤āĻšাāĻĒ āĻĻেāĻ–া āĻĻিāĻ¤ে āĻĒাāĻ°ে। āĻ•্āĻ¯াāĻ˛āĻ¸িāĻ¯়াāĻŽ āĻš্āĻ¯াāĻ¨েāĻ˛ āĻŦ্āĻ˛āĻ•াāĻ° āĻ¨াāĻ‡āĻŸ্āĻ°েāĻŸāĻ¸ āĻāĻ• āĻ¸াāĻĨে āĻŦ্āĻ¯āĻŦāĻšাāĻ° āĻ•āĻ°া āĻšāĻ˛ে āĻ…āĻ°্āĻĨোāĻ¸্āĻŸ্āĻ¯াāĻŸিāĻ• āĻ¨িāĻŽ্āĻ¨ āĻ°āĻ•্āĻ¤āĻšাāĻĒ āĻšāĻ¤ে āĻĒাāĻ°ে। āĻ¨াāĻ‡āĻŸ্āĻ°েāĻŸāĻ¸ āĻāĻŦং āĻāĻ˛āĻ•োāĻšāĻ˛ āĻāĻ•āĻ¸াāĻĨে āĻ—্āĻ°āĻšāĻŖ āĻ•āĻ°āĻ˛েāĻ“ āĻ¨িāĻŽ্āĻ¨ āĻ°āĻ•্āĻ¤āĻšাāĻĒ āĻĻেāĻ–া āĻĻিāĻ¤ে āĻĒাāĻ°ে। āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻāĻ° āĻ­্āĻ¯াāĻ¸োāĻĄাāĻ¯়াāĻ˛েāĻŸāĻ°ী āĻāĻŦং āĻšেāĻŽোāĻĄাāĻ¯়āĻ¨াāĻŽিāĻ• āĻĒ্āĻ°āĻ­াāĻŦ āĻāĻ¸āĻĒিāĻ°িāĻ¨ āĻ—্āĻ°āĻšāĻŖেāĻ° āĻ¸াāĻĨে āĻŦৃāĻĻ্āĻ§ি āĻĒেāĻ¤ে āĻĒাāĻ°ে। āĻ¯ে āĻ¸āĻŦ āĻ°োāĻ—ী āĻ¸াāĻŦ-āĻ˛িāĻ™্āĻ—ুāĻ¯়েāĻ˛ āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻ—্āĻ°āĻšāĻŖ āĻ•āĻ°āĻ›ে āĻ¤াāĻĻেāĻ°āĻ•ে āĻ†āĻ°্āĻ—োāĻŸাāĻŽিāĻ¨ āĻāĻŦং āĻ†āĻ°্āĻ—োāĻŸাāĻŽিāĻ¨ āĻœাāĻ¤ীāĻ¯় āĻ“āĻˇুāĻ§ āĻ—্āĻ°āĻšāĻŖ āĻĨেāĻ•ে āĻŦিāĻ°āĻ¤ āĻĨাāĻ•āĻ¤ে āĻšāĻŦে āĻ…āĻĨāĻŦা āĻ†āĻ°্āĻ—োāĻŸিāĻœāĻŽ āĻāĻ° āĻ˛āĻ•্āĻˇāĻŖāĻ—ুāĻ˛ো āĻĒāĻ°্āĻ¯āĻŦেāĻ•্āĻˇāĻŖ āĻ•āĻ°āĻ¤ে āĻšāĻŦে।

āĻ—āĻ°্āĻ­াāĻŦāĻ¸্āĻĨাāĻ¯় āĻ“ āĻ¸্āĻ¤āĻ¨্āĻ¯āĻĻাāĻ¨āĻ•াāĻ˛ে āĻŦ্āĻ¯āĻŦāĻšাāĻ° : āĻ—āĻ°্āĻ­াāĻŦāĻ¸্āĻĨাāĻ¯় āĻ“ āĻ¸্āĻ¤āĻ¨্āĻ¯āĻĻাāĻ¨āĻ•াāĻ˛ে āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻāĻ° āĻ¨িāĻ°াāĻĒāĻ¤্āĻ¤াāĻ° āĻ•োāĻ¨ āĻĒ্āĻ°āĻŽাāĻŖ āĻĒাāĻ“āĻ¯়া āĻ¯াāĻ¯়āĻ¨ি। āĻšিāĻ•িā§ŽāĻ¸āĻ•েāĻ° āĻĒāĻ°াāĻŽāĻ°্āĻļ āĻ›াāĻĄ়া āĻ—āĻ°্āĻ­াāĻŦāĻ¸্āĻĨা āĻ“ āĻ¸্āĻ¤āĻ¨্āĻ¯āĻĻাāĻ¨āĻ•াāĻ°ী āĻŽাāĻ¯়েāĻĻেāĻ° āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻĻেāĻ¯়া āĻ‰āĻšিāĻ¤ āĻšāĻŦে āĻ¨া। āĻŽাāĻ¤ৃāĻĻুāĻ—্āĻ§ে āĻ¨াāĻ‡āĻŸ্āĻ°োāĻ—্āĻ˛িāĻ¸াāĻ°িāĻ¨ āĻ¨িঃāĻ¸ৃāĻ¤ āĻšāĻ¯় āĻ•িāĻ¨া āĻ¤া āĻœাāĻ¨া āĻ¯াāĻ¯়āĻ¨ি।

āĻļিāĻļুāĻĻেāĻ° āĻ•্āĻˇেāĻ¤্āĻ°ে āĻŦ্āĻ¯āĻŦāĻšাāĻ° : āĻļিāĻļুāĻĻেāĻ° āĻœāĻ¨্āĻ¯ āĻ¨িāĻ°্āĻĻেāĻļিāĻ¤ āĻ¨āĻ¯়।

Post a Comment

0 Comments

advertisement

advertisement